Slow-progressing diseases detected earlier with MRI

MRI can be used to detect subtle changes in muscle tissue that allow early diagnosis of slowly progressing conditions, including facioscapulohumeral muscular dystrophy.

A recent study in the journal PLoS ONE looked at MRI as a way to detect FSHD, a disorder that affects face, shoulder, and arm muscles. According to a report in Muscular Dystrophy News, "doctors have difficulty evaluating FSHD muscle changes and the disease’s progression because current testing methods are unable to detect small differences occurring over short periods. Making it more challenging is that patients who are motivated can appear to have better muscle performance than they actually do."

“This slow disease progression and the poor sensitivity of the commonly used clinical scores mandates the utilization of more sensitive biomarkers which could be used to appropriately assess disease progression and the potential effects of therapeutic interventions,” the researchers wrote.

See the full article here:

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.